Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance
- PMID: 16952545
- PMCID: PMC3086734
- DOI: 10.1053/j.gastro.2006.07.001
Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance
Abstract
Background & aims: Hemophilic siblings provide a unique population to explore the natural history of chronic hepatitis C.
Methods: From 3993 hemophilic patients with hepatitis C, 257 sibling pairs, of which both members had evidence of hepatitis C infection, were studied to evaluate the genetic contribution to spontaneous and treatment-induced clearance of hepatitis C infection and progression of liver disease. Familial aggregation was assessed by comparing observed probabilities of concordance for these disease characteristics within sibling pairs to those expected for randomly paired hemophilic subjects. Additional measures of familial aggregation, heritability, and sibling relative risk were also calculated.
Results: Among human immunodeficiency virus-negative subjects, concordance for spontaneous viral clearance was 2-fold higher in siblings compared with randomly paired subjects (8.8% vs 4.3%, respectively, P = .04). Similarly, the concordance rate for treatment-related viral clearance was over twice that among sibling pairs than among randomly paired hemophiliacs (31.3% vs 13.3%, respectively, P = ns). Heritability estimates for spontaneous and treatment-induced viral clearance were 0.24 +/- 0.14 (P = .04) and 0.43 +/- 0.42 (P = .10), respectively. The sibling relative risks for these respective characteristics were 1.6 and 1.7. Concordance for advanced liver disease was higher among siblings but did not reach statistical significance (4.0% vs 2.3%, respectively, P = ns). The heritability estimate was 0.29 +/- 0.13 (P = .02).
Conclusions: Concordance rates and heritability estimates for spontaneous and treatment-related viral clearance indicate that genetic factors have a modest influence on the outcome of hepatitis C, although shared environmental factors cannot be excluded. Investigations to map candidate disease-susceptibility genes associated with these characteristics must be approached with caution.
Comment in
-
The host or the virus? Impact of genetic factors on the outcome of hepatitis C virus infection.Gastroenterology. 2006 Sep;131(3):954-6. doi: 10.1053/j.gastro.2006.07.031. Gastroenterology. 2006. PMID: 16952564 No abstract available.
-
HCV clearance among hemophiliacs and beta-thalassemics.Gastroenterology. 2007 Apr;132(4):1634. doi: 10.1053/j.gastro.2007.03.007. Gastroenterology. 2007. PMID: 17418167 No abstract available.
References
-
- Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–562. - PubMed
-
- Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med. 1999;340:1228–1233. - PubMed
-
- Fanning L, Kenny E, Sheehan M, Cannon B, Whelton M, O’Connell J, Collins JK, et al. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. Hepatology. 1999;29:904–907. - PubMed
-
- Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study. Hepatology. 2000;32:91–96. - PubMed
-
- National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002) Gastroenterology. 2002;123:2082–2099. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
